HRT Financial’s Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant MACC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65,220
Closed -$640K 3730
2022
Q3
$640K Hold
65,220
0.01% 1285
2022
Q2
$637K Hold
65,220
0.01% 1317
2022
Q1
$639K Hold
65,220
﹤0.01% 1455
2021
Q4
$645K Hold
65,220
﹤0.01% 1568
2021
Q3
$645K Hold
65,220
﹤0.01% 1764
2021
Q2
$651K Hold
65,220
0.01% 1538
2021
Q1
$648K Buy
+65,220
New +$650K 0.01% 1580

HRT Financial's MACC.U Position: Q4 2022 in Review

HRT Financial sold out of Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant (MACC.U) in Q4 2022, closing a stake of 65,220 shares — an estimated $640K sold.

HRT Financial first reported a position in MACC.U in Q1 2021 and held it in 7 quarters. The position peaked at $651K in Q2 2021. 0 funds tracked by Wall St. Rank hold MACC.U as of Q4 2022.

  • HRT Financial reported no remaining Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 65,220 Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant shares in Q4 2022, an estimated $640K.
  • HRT Financial first reported a position in Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant in Q1 2021 and held it in 7 quarters.
  • HRT Financial's Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant position peaked at $651K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.